Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weinaian Capsule (Weinai An Jiaonang) is a traditional Chinese medicine (TCM) herbal formulation developed and marketed by Guangzhou Baiyun Mountain Zhongyi Pharmaceutical. It is composed of five key ingredients: Radix Astragali (Huangqi), Radix Notoginseng (Sanqi), Radix Ginseng Rubra (red ginseng), pearl layer powder (Margarita), and artificial Calculus Bovis (artificial bezoar). Indicated for the treatment of gastric and duodenal ulcers, chronic gastritis, and gastrointestinal mucosal injury, the drug functions by promoting Qi and blood flow, exerting anti-inflammatory effects, and stimulating tissue regeneration. Research indicates its mechanism involves the modulation of the PI3K/AKT/mTOR signaling pathway and the regulation of the gut microbiome to protect the gastric and intestinal mucosa. It is recognized as a National Protected TCM Variety in China and is included in the Chinese Pharmacopoeia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Weinaian Capsule.